skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: Nome da Publicação: Clinical Therapeutics remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Role of RANK Ligand and Denosumab, a Targeted RANK Ligand Inhibitor, in Bone Health and Osteoporosis: A Review of Preclinical and Clinical Data
Role of RANK Ligand and Denosumab, a Targeted RANK Ligand Inhibitor, in Bone Health and Osteoporosis: A Review of Preclinical and Clinical Data
Material Type:
Artigo 		Adicionar ao Meu Espaço

Role of RANK Ligand and Denosumab, a Targeted RANK Ligand Inhibitor, in Bone Health and Osteoporosis: A Review of Preclinical and Clinical Data

Dempster, David W., PhD ; Lambing, Cheryl L., MD ; Kostenuik, Paul J., PhD ; Grauer, Andreas, MD

Clinical therapeutics, 2012-03, Vol.34 (3), p.521-536 [Periódico revisado por pares]

United States: EM Inc USA

Texto completo disponível

Citações Citado por
2
The bone quality framework: Determinants of bone strength and their interrelationships, and implications for osteoporosis management
The bone quality framework: Determinants of bone strength and their interrelationships, and implications for osteoporosis management
Material Type:
Artigo 		Adicionar ao Meu Espaço

The bone quality framework: Determinants of bone strength and their interrelationships, and implications for osteoporosis management

Felsenberg, Dieter ; Boonen, Steven

Clinical therapeutics, 2005, Vol.27 (1), p.1-11 [Periódico revisado por pares]

Belle Mead, NJ: EM Inc USA

Texto completo disponível

Citações Citado por
3
The Pathophysiology and Treatment of Osteoporosis
The Pathophysiology and Treatment of Osteoporosis
Material Type:
Artigo 		Adicionar ao Meu Espaço

The Pathophysiology and Treatment of Osteoporosis

Drake, Matthew T., MD, PhD ; Clarke, Bart L., MD ; Lewiecki, E. Michael, MD, FACP, FACE

Clinical therapeutics, 2015-08, Vol.37 (8), p.1837-1850 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
4
Importance of Time Point–Specific Indirect Treatment Comparisons of Osteoporosis Treatments: A Systematic Literature Review and Network Meta-Analyses
Importance of Time Point–Specific Indirect Treatment Comparisons of Osteoporosis Treatments: A Systematic Literature Review and Network Meta-Analyses
Material Type:
Artigo 		Adicionar ao Meu Espaço

Importance of Time Point–Specific Indirect Treatment Comparisons of Osteoporosis Treatments: A Systematic Literature Review and Network Meta-Analyses

Willems, Damon ; Javaid, Muhammad Kassim ; Pinedo-Villanueva, Rafael ; Libanati, Cesar ; Yehoshua, Alon ; Charokopou, Mata

Clinical therapeutics, 2022-01, Vol.44 (1), p.81-97 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
5
Proportion and Characteristics of Patients in Sweden Remaining at High Risk of Fracture Despite Prior Treatment
Proportion and Characteristics of Patients in Sweden Remaining at High Risk of Fracture Despite Prior Treatment
Material Type:
Artigo 		Adicionar ao Meu Espaço

Proportion and Characteristics of Patients in Sweden Remaining at High Risk of Fracture Despite Prior Treatment

Mellström, Dan, MD ; Yang, Xiaoqin, PhD ; Li, Zhiyi, MA, MBA ; Fan, Chun-Po Steve, PhD ; Waern, Ewa, Research Fellow, MD ; Modi, Ankita, PhD ; Sajjan, Shiva, PhD ; Salomonsson, Stina, PhD

Clinical therapeutics, 2016-07, Vol.38 (7), p.1686-1695.e3 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
6
Assessing compliance, acceptance, and tolerability of teriparatide in patients with osteoporosis who fractured while on antiresorptive treatment or were intolerant to previous antiresorptive treatment: An 18-month, multicenter, open-label, prospective study
Assessing compliance, acceptance, and tolerability of teriparatide in patients with osteoporosis who fractured while on antiresorptive treatment or were intolerant to previous antiresorptive treatment: An 18-month, multicenter, open-label, prospective study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Assessing compliance, acceptance, and tolerability of teriparatide in patients with osteoporosis who fractured while on antiresorptive treatment or were intolerant to previous antiresorptive treatment: An 18-month, multicenter, open-label, prospective study

Adachi, Jonathan D., MD, FRCPC ; Hanley, David A., MD, FRCPC ; Lorraine, Joanne K., MD, FRCPC ; Yu, Maria, MSc

Clinical therapeutics, 2007-09, Vol.29 (9), p.2055-2067 [Periódico revisado por pares]

Belle Mead, NJ: EM Inc USA

Texto completo disponível

Citações Citado por
7
Relationship Between Gastrointestinal Events and Compliance With Osteoporosis Therapy: An Administrative Claims Analysis of the US Managed Care Population
Relationship Between Gastrointestinal Events and Compliance With Osteoporosis Therapy: An Administrative Claims Analysis of the US Managed Care Population
Material Type:
Artigo 		Adicionar ao Meu Espaço

Relationship Between Gastrointestinal Events and Compliance With Osteoporosis Therapy: An Administrative Claims Analysis of the US Managed Care Population

Modi, Ankita, PhD ; Sajjan, Shiva, PhD ; Michael Lewiecki, E., MD, FACP, FACE ; Harris, Steven T., MD, FACP ; Papadopoulos Weaver, Jessica, MPH

Clinical therapeutics, 2016-05, Vol.38 (5), p.1074-1080 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
8
A Review of the Literature on Osteonecrosis of the Jaw in Patients with Osteoporosis Treated with Oral Bisphosphonates: Prevalence, Risk Factors, and Clinical Characteristics
A Review of the Literature on Osteonecrosis of the Jaw in Patients with Osteoporosis Treated with Oral Bisphosphonates: Prevalence, Risk Factors, and Clinical Characteristics
Material Type:
Artigo 		Adicionar ao Meu Espaço

A Review of the Literature on Osteonecrosis of the Jaw in Patients with Osteoporosis Treated with Oral Bisphosphonates: Prevalence, Risk Factors, and Clinical Characteristics

Pazianas, Michael, MD ; Miller, Paul, MD ; Blumentals, William A., PhD ; Bernal, Myriam, MD, MPH ; Kothawala, Prajesh, MD, MPH

Clinical therapeutics, 2007-08, Vol.29 (8), p.1548-1558 [Periódico revisado por pares]

Belle Mead, NJ: EM Inc USA

Texto completo disponível

Citações Citado por
9
Real-world Adherence and Persistence with Bisphosphonate Therapy in Postmenopausal Women: A Systematic Review
Real-world Adherence and Persistence with Bisphosphonate Therapy in Postmenopausal Women: A Systematic Review
Material Type:
Artigo 		Adicionar ao Meu Espaço

Real-world Adherence and Persistence with Bisphosphonate Therapy in Postmenopausal Women: A Systematic Review

Fardellone, Patrice, MD ; Lello, Stefano, MD ; Cano, Antonio, MD ; de Sá Moreira, Eloisa, PhD ; Watanabe de Oliveira, Renato, MS ; Julian, Guilherme Silva, MS ; Tang, Boxiong, MD

Clinical therapeutics, 2019-08, Vol.41 (8), p.1576-1588 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
10
The Safety and Efficacy of Abaloparatide on Postmenopausal Osteoporosis: A Systematic Review and Meta-analysis
The Safety and Efficacy of Abaloparatide on Postmenopausal Osteoporosis: A Systematic Review and Meta-analysis
Material Type:
Artigo 		Adicionar ao Meu Espaço

The Safety and Efficacy of Abaloparatide on Postmenopausal Osteoporosis: A Systematic Review and Meta-analysis

Xu, Fuxin ; Wang, Yurun ; Zhu, Xinjian

Clinical therapeutics, 2024-03, Vol.46 (3), p.267-274 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Recursos Online (101)

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.